{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:25:32Z","timestamp":1780406732885,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Current research IRCCS"],"award-info":[{"award-number":["Current research IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03961-x","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:55:31Z","timestamp":1761652531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers trajectories in critically ill patients with COVID-19 acute respiratory distress syndrome: insights from latent class growth analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Fabiana","family":"Madotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Guzzardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Carlesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Calfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Delucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Scaravilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Panigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ferraris Fusarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tornese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"8","key":"3961_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611\u201320.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3961_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","volume":"8","author":"P Sinha","year":"2020","unstructured":"Sinha P, Delucchi KL, McAuley DF, O\u2019Kane CM, Matthay MA, Calfee CS. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med. 2020;8(3):247\u201357.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"3961_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13054-024-04819-0","volume":"28","author":"N Alipanah-Lechner","year":"2024","unstructured":"Alipanah-Lechner N, Hurst-Hopf J, Delucchi K, et al. Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial. Crit Care. 2024;28(1):56.","journal-title":"Crit Care"},{"issue":"9","key":"3961_CR4","first-page":"995","volume":"47","author":"A Zanella","year":"2021","unstructured":"Zanella A, Florio G, Antonelli M, et al. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med. 2021;47(9):995\u20131008.","journal-title":"Intensive Care Med"},{"issue":"12","key":"3961_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S2213-2600(21)00365-9","volume":"9","author":"LDJ Bos","year":"2021","unstructured":"Bos LDJ, Sjoding M, Sinha P, et al. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. Lancet Respir Med. 2021;9(12):1377\u201386.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"3961_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1164\/rccm.202308-1490OC","volume":"209","author":"P Sinha","year":"2024","unstructured":"Sinha P, Neyton L, Sarma A, et al. Molecular phenotypes of acute respiratory distress syndrome in the ROSE trial have differential outcomes and gene expression patterns that differ at baseline and longitudinally over time. Am J Respir Crit Care Med. 2024;209(7):816\u201328.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3961_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-021-03552-2","volume":"25","author":"T Langer","year":"2021","unstructured":"Langer T, Brioni M, Guzzardella A, et al. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021;25(1):128.","journal-title":"Crit Care"},{"issue":"2","key":"3961_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","volume":"160","author":"G Grasselli","year":"2021","unstructured":"Grasselli G, Scaravilli V, Mangioni D, et al. Hospital-Acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454\u201365.","journal-title":"Chest"},{"issue":"1","key":"3961_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13054-022-04049-2","volume":"26","author":"V Scaravilli","year":"2022","unstructured":"Scaravilli V, Guzzardella A, Madotto F, et al. Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study. Crit Care. 2022;26(1):176.","journal-title":"Crit Care"},{"key":"3961_CR10","doi-asserted-by":"publisher","first-page":"100323","DOI":"10.1016\/j.alcr.2019.100323","volume":"43","author":"G van der Nest","year":"2020","unstructured":"van der Nest G, Lima Passos V, Candel MJJM, van Breukelen GJP. An overview of mixture modelling for latent evolutions in longitudinal data: modelling approaches, fit statistics and software. Adv Life Course Res. 2020;43:100323.","journal-title":"Adv Life Course Res"},{"issue":"3","key":"3961_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10654-020-00615-6","volume":"35","author":"M Herle","year":"2020","unstructured":"Herle M, Micali N, Abdulkadir M, et al. Identifying typical trajectories in longitudinal data: modelling strategies and interpretations. Eur J Epidemiol. 2020;35(3):205\u201322.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"3961_CR12","first-page":"169","volume":"41","author":"RM Sakia","year":"1992","unstructured":"Sakia RM. The Box-Cox transformation technique: A review. J Royal Stat Soc Ser D (The Statistician). 1992;41(2):169\u201378.","journal-title":"J Royal Stat Soc Ser D (The Statistician)"},{"issue":"361","key":"3961_CR13","doi-asserted-by":"publisher","first-page":"ra11","DOI":"10.1126\/scisignal.2005548","volume":"8","author":"M Deng","year":"2015","unstructured":"Deng M, Loughran PA, Zhang L, Scott MJ, Billiar TR. Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling. Sci Signal. 2015;8(361):ra11.","journal-title":"Sci Signal"},{"issue":"11","key":"3961_CR14","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","volume":"89","author":"KJ Van Zee","year":"1992","unstructured":"Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A. 1992;89(11):4845\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3961_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1084\/jem.175.2.323","volume":"175","author":"D Aderka","year":"1992","unstructured":"Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 1992;175(2):323\u20139.","journal-title":"J Exp Med"},{"issue":"2","key":"3961_CR16","first-page":"175","volume":"16","author":"M Pellin","year":"1986","unstructured":"Pellin M. [Ordering from the dental warehouse]. Quintessenz J. 1986;16(2):175\u20137.","journal-title":"Quintessenz J"},{"key":"3961_CR17","doi-asserted-by":"publisher","first-page":"155727","DOI":"10.1016\/j.cyto.2021.155727","volume":"149","author":"E Sancho Ferrando","year":"2022","unstructured":"Sancho Ferrando E, Hanslin K, Hultstr\u00f6m M, et al. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine. 2022;149:155727.","journal-title":"Cytokine"},{"issue":"12","key":"3961_CR18","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1097\/CCM.0b013e31829eb98f","volume":"41","author":"AW Artenstein","year":"2013","unstructured":"Artenstein AW, Higgins TL, Opal SM. Sepsis and scientific revolutions. Crit Care Med. 2013;41(12):2770\u20132.","journal-title":"Crit Care Med"},{"issue":"7","key":"3961_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","volume":"49","author":"G Grasselli","year":"2023","unstructured":"Grasselli G, Calfee CS, Camporota L, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023;49(7):727\u201359.","journal-title":"Intensive Care Med"},{"issue":"3","key":"3961_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000342333","volume":"36","author":"MM Speeckaert","year":"2012","unstructured":"Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36(3):261\u201370.","journal-title":"Am J Nephrol"},{"issue":"1","key":"3961_CR21","doi-asserted-by":"publisher","first-page":"2311316","DOI":"10.1080\/0886022X.2024.2311316","volume":"46","author":"Z He","year":"2024","unstructured":"He Z, Liu JJ, Ma SL. Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury. Ren Fail. 2024;46(1):2311316.","journal-title":"Ren Fail"},{"issue":"3","key":"3961_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/CCM.0b013e318206b3ca","volume":"39","author":"M Jabaudon","year":"2011","unstructured":"Jabaudon M, Futier E, Roszyk L, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med. 2011;39(3):480\u20138.","journal-title":"Crit Care Med"},{"issue":"11","key":"3961_CR23","doi-asserted-by":"publisher","first-page":"e1468","DOI":"10.1002\/cti2.1468","volume":"12","author":"X Deng","year":"2023","unstructured":"Deng X, Gantner P, Forestell J, et al. Plasma SARS-CoV-2 RNA elimination and RAGE kinetics distinguish COVID-19 severity. Clin Transl Immunol. 2023;12(11):e1468.","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"3961_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-021-03499-4","volume":"25","author":"S Spadaro","year":"2021","unstructured":"Spadaro S, Fogagnolo A, Campo G, et al. Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients. Crit Care. 2021;25(1):74.","journal-title":"Crit Care"},{"issue":"9","key":"3961_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/thorax-2023-219989","volume":"78","author":"J de Brabander","year":"2023","unstructured":"de Brabander J, Boers LS, Kullberg RFJ, et al. Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality. Thorax. 2023;78(9):912\u201321.","journal-title":"Thorax"},{"issue":"1","key":"3961_CR26","doi-asserted-by":"publisher","first-page":"17114","DOI":"10.1038\/s41598-023-44463-2","volume":"13","author":"M Marko","year":"2023","unstructured":"Marko M, Pawliczak R. Assessment of the available therapeutic approaches for severe COVID-19: a meta-analysis of randomized controlled trials. Sci Rep. 2023;13(1):17114.","journal-title":"Sci Rep"},{"issue":"9","key":"3961_CR27","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","volume":"180","author":"P Sinha","year":"2020","unstructured":"Sinha P, Matthay MA, Calfee CS. Is a cytokine storm relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152\u20134.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"3961_CR28","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","volume":"8","author":"DE Leisman","year":"2020","unstructured":"Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8(12):1233\u201344.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3961_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.202406-1241OC","volume":"211","author":"RBE van Amstel","year":"2025","unstructured":"van Amstel RBE, Bartek B, Vlaar APJ, et al. Temporal transitions of the hyperinflammatory and hypoinflammatory phenotypes in critical illness. Am J Respir Crit Care Med. 2025;211(3):347\u201356.","journal-title":"Am J Respir Crit Care Med"},{"key":"3961_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fnins.2017.00315","volume":"11","author":"JM Felt","year":"2017","unstructured":"Felt JM, Depaoli S, Tiemensma J. Latent growth curve models for biomarkers of the stress response. Front Neurosci. 2017;11:315.","journal-title":"Front Neurosci"},{"issue":"4","key":"3961_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0095798420930932","volume":"46","author":"BE Weller","year":"2020","unstructured":"Weller BE, Bowen NK, Faubert SJ. Latent class analysis: A guide to best practice. J Black Psychol. 2020;46(4):287\u2013311.","journal-title":"J Black Psychol"},{"issue":"7","key":"3961_CR32","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Methods Med Res. 2018;27(7):2015\u201323.","journal-title":"Stat Methods Med Res"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03961-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03961-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03961-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:04:48Z","timestamp":1761696288000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03961-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3961"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03961-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The 2019nCoV-ICU study was conducted in accordance with the Declaration of Helsinki and received approval from the Ethical Committee of the promoting centre \u2013 Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico (Milano), Comitato Etico Milano Area 2 (protocol no. 0008489; approval date: March 20, 2020). The other participating institutions, together with their respective Ethical Committees that approved the study, are listed in the Supplementary Material.\u00a0The study was registered on ClinicalTrails.gov (Clinical Trial Number: NCT04388670; Registration Date: 2020-05-12). Written informed consent was deferred or waived as per local regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GG received grants and research supports from Fischer&Paykel, MSD, Pfizer. GG participated in a company sponsored speaker\u2019s bureau: Getinge, Draeger, Fischer&Paykel, Mundipharma, Viatris. CC receives research funding from the NIH, FDA, DOD, Roche-Genentech, and Quantum Leap Healthcare Collaborative. Additionally, she provides consulting services to Janssen, Vasomune, Gen1e Life Sciences, NGMBio, Calcimedica, Arrowhead, EnliTISA, Novartis, Quark Pharmaceuticals, and Cellenkos. She is also a co-recipient of a patent and serves as a council member of the International Sepsis Forum. The remaining authors have disclosed that they do not have any potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"497"}}